Literature DB >> 33258397

Nicolau Syndrome Secondary to Subcutaneous Glatiramer Acetate Injection.

Caner Demircan1, Neslihan Akdogan1, Leyla Elmas1.   

Abstract

Nicolau syndrome, also known as embolia cutis medicamentosa, is a rare complication of injectable drugs. Patients present with pain at injection site, followed by swelling, erythema, purple, hemorrhagic patches and lastly ulcer formation. A variety of intramuscular agents have been implicated as responsible. We report a case of a 26-year-old woman with a history of a purple lesion on her thigh who was diagnosed with Nicolau syndrome due to subcutaneous administration of glatiramer acetate. The patient was followed up with topical mupirocin. On follow-up, although the patient stated that she continued using glatiramer acetate, no new lesions appeared and the existing lesion continued to shrink. Nicolau syndrome seems to have an unpredictable and unavoidable course. This case suggests that physicians should have a high index of suspicion for the presence of Nicolau syndrome in patients presenting with necrotic or ulcerative lesions with a history of using injectable drugs.

Entities:  

Keywords:  Nicolau syndrome; glatiramer acetate; subcutaneous injection; ulcerative lesion

Year:  2020        PMID: 33258397     DOI: 10.1177/1534734620973144

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  1 in total

Review 1.  Nicolau syndrome following subcutaneous glatiramer acetate injection: A case report and review of the literature.

Authors:  Pelin Esme; Irfan Gahramanov; Egemen Akıncıoglu; Gulsen Akoglu
Journal:  Indian J Pharmacol       Date:  2021 Nov-Dec       Impact factor: 1.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.